首页> 美国卫生研究院文献>Springer Open Choice >Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term randomised open-label study

【2h】

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term randomised open-label study

机译：甘精胰岛素和中性鱼精蛋白Hagedorn（NPH）胰岛素在2型糖尿病患者中的糖尿病视网膜病变进展相似：一项长期开放标签研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims/hypothesisThis long-term study was designed to further characterise the retinal safety profile of insulin glargine and human neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes mellitus.

机译：目的/假设这项长期研究旨在进一步表征2型糖尿病患者中的甘精胰岛素和人中性鱼精蛋白Hagedorn（NPH）胰岛素的视网膜安全性。

著录项

期刊名称 Springer Open Choice
作者
J. Rosenstock; V. Fonseca; J. B. McGill; M. Riddle; J.-P. Hallé; I. Hramiak; P. Johnston; M. Davis;
展开▼
作者单位

展开▼
年(卷),期 -1(52),9
年度 -1
页码 1778–1788
总页数 11
原文格式 PDF
正文语种
中图分类外科学;
关键词
CSME ETDRS Insulin action Insulin glargine Insulin therapy NPH insulin Retinopathy Type 2 diabetes;

机译：CSME;ETDRS;胰岛素作用;甘精胰岛素;胰岛素治疗;NPH胰岛素;视网膜病变;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Reply to Chantelau E [letter] and Currie CJ [letter] [J] . J. Rosenstock, V. Fonseca, J. B. McGill, Diabetologia . 2009,第10期

机译：2型糖尿病患者使用甘精胰岛素和中性鱼精蛋白Hagedorn（NPH）胰岛素治疗糖尿病性视网膜病变的相似进展：一项长期，开放性研究。回覆Chantelau E [信]和Currie CJ [信]
2. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study [J] . J. Rosenstock, V. Fonseca, J. B. McGill, Diabetologia . 2009,第9期

机译：甘精胰岛素和中性鱼精蛋白Hagedorn（NPH）胰岛素在2型糖尿病患者中的糖尿病视网膜病变进展相似：一项长期，开放标签研究
3. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Reply to Chantelau E [letter] and Currie CJ [letter] [J] . J. Rosenstock, V. Fonseca, J. B. McGill, Diabetologia: clinical and experimental diabetes and metabolism . 2009,第10期

机译：2型糖尿病患者使用甘精胰岛素和中性鱼精蛋白哈格多恩（NPH）胰岛素治疗糖尿病性视网膜病变的相似进展：一项长期，开放性研究。回覆Chantelau E [信]和Currie CJ [信]
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. A randomized, open-label, intervention study to evaluate the effect of diet composition on weight gain in obese, type 2 diabetes patients receiving intensive insulin therapy. [D] . Villareal, Roland. 2008

机译：一项随机，开放标签，干预性研究，以评估饮食结构对接受强化胰岛素治疗的肥胖2型糖尿病患者体重增加的影响。
6. Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised open-label study [O] . J. Rosenstock, V. Fonseca, J. B. McGill, -1

机译：2型糖尿病患者使用甘精胰岛素和中性鱼精蛋白Hagedorn（NPH）胰岛素发生恶性肿瘤的风险相似：一项为期5年的随机开放标签研究的结果
7. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study [O] . 2009

机译：甘精胰岛素和中性鱼精蛋白Hagedorn（NPH）胰岛素在2型糖尿病患者中的糖尿病视网膜病变进展相似：一项长期，开放标签研究

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term randomised open-label study

摘要

著录项

相似文献

相关主题

期刊订阅